Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gaia Mazzocchetti
Observed name:
G. Mazzocchetti
Institutions:
Italian Institute of Technology,
University of Bologna
Observed institutions:
University Hospital Heidelberg,
Italian Institute of Technology,
Istituto di Ematologia di Bologna,
University of Bologna
ORCID:
0000-0002-7387-3406
Observed ORCID:
0000-0002-7387-3406
OpenAlex ID:
A5056556752
High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis
2024
·
Marina Martello
, Vincenza Solli
, et al.
·
Blood Cancer Journal
·
25
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases
2022
·
Ilaria Vigliotta
, Silvia Armuzzi
, et al.
·
Frontiers in Oncology
·
14
PDF
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features
2024
·
Carolina Terragna
, Andrea Poletti
, et al.
·
Nature Communications
·
13
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients
2024
·
Enrica Borsi
, Ilaria Vigliotta
, et al.
·
Cells
·
11
PDF
Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients
2024
·
Ilaria Vigliotta
, Vincenza Solli
, et al.
·
Cancers
·
9
PDF
Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma
2025
·
Andrea Poletti
, Barbara Taurisano
, et al.
·
Haematologica
·
8
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients
2023
·
Enrica Borsi
, Gaia Mazzocchetti
, et al.
·
Clinical and Experimental Medicine
·
7
PDF
BoBafit : A copy number clustering tool designed to refit and recalibrate the baseline region of tumors’ profiles
2022
·
G. Mazzocchetti
, A. Poletti
, et al.
·
Computational and Structural Biotechnology Journal
·
7
Ten-year experience on home care for patients with plasma cell disorders: bringing optimal therapy home
2025
·
Flavia Bigi
, Mauro Fiacchini
, et al.
·
Clinical and Experimental Medicine
·
4
PDF
Interference of daratumumab and efficacy of plerixafor on haematopoietic stem cell collection in Multiple Myeloma
2024
·
Flavia Bigi
, Paola Tacchetti
, et al.
·
Frontiers in Hematology
·
2
PDF
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients
2022
·
Marina Martello
, Vincenza Solli
, et al.
·
International Journal of Molecular Sciences
·
2
PDF
T Cell/Natural Killer (NK) Cell Transcriptional Profiles Are Associated with Response to Gilteritinib in FLT3-Mutated Acute Myeloid Leukemia
2023
·
Jacopo Nanni
, Jayakumar Vadakekolathu
, et al.
·
Blood
·
1
Mesenchymal Stromal Cells Protect Acute Myeloid Leukemia Cells from Venetoclax-Induced Apoptosis through Contact-Dependent Mechanisms
2022
·
Giulia Corradi
, Samantha Bruno
, et al.
·
Blood
·
1
OAB-059: Towards a comprehensive multimodal minimal residual disease assessment in multiple myeloma: the role of circulating cell-free DNA to define the extent of disease spreading
2021
·
Marina Martello
, Andrea Poletti
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
OA-36 Longitudinal Liquid Biopsy Monitoring Reveals Distinct Residual Disease Dynamics Beyond Bone Marrow MRD Assessment in Newly Diagnosed Multiple Myeloma
2026
·
Carolina Terragna
, Vincenza Solli
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
PA-051 Beyond Consensus Genomic Staging: Genomic Heterogeneity of Relapsed Standard-Risk Multiple Myeloma
2026
·
Viola Meixian Vuong
, Vincenza Solli
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
PA-026 An Integrated High-Sensitivity Flow Cytometry Platform Revealing Dissemination-Associated Phenotypes and Therapeutic Target Heterogeneity in Multiple Myeloma: The MMulticolors Panel
2026
·
Alessia Varacalli
, Ilaria Vigliotta
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
PA-285 Longitudinal ctDNA Profiling Enables Early Detection of Relapse and Clonal Dynamics in Multiple Myeloma
2026
·
Marina Martello
, Gaia Mazzocchetti
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Circulating plasma cells (polyclonal and monoclonal) as markers of an aggressive multiple myeloma phenotype
2026
·
Ilaria Vigliotta
, Alessia Varacalli
, et al.
·
Scientific Reports
PDF
P46 | Circulating Plasma Cells as a Dynamic Biomarker in Multiple Myeloma Patients Receiving Car-t and Bispecific Antibody Therapy
2026
·
I. Vigliotta
, A. Varacalli
, et al.
·
Haematologica
PDF
P16 | INTEGRATED p53 ISOFORM EXPRESSION DEFINES NOVEL PROGNOSTIC SUBGROUPS IN MULTIPLE MYELOMA
2026
·
E. Borsi
, A. Vitale
, et al.
·
Haematologica
PDF
P18 | Monoclonal and Polyclonal Circulating Plasma Cells Are Associated With Disease Dissemination in Multiple Myeloma
2026
·
I. Vigliotta
, A. Varacalli
, et al.
·
Haematologica
PDF
Monoclonal and polyclonal circulating plasma cells (CPCs) are linked to disease spread in multiple myeloma
2025
·
Ilaria Vigliotta
, Alessia Varacalli
, et al.
·
Blood
PDF
Charting Spatial Heterogeneity in Multiple Myeloma by Using a Minimally Invasive Cell-free DNA Profiling
2025
·
Marina Martello
, Gaia Mazzocchetti
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
T/NK Cell-Associated Transcriptomic Profile Informs Response to FLT3 Inhibitors in Acute Myeloid Leukemia
2024
·
Jacopo Nanni
, Jayakumar Vadakekolathu
, et al.
·
Blood
PDF
Show more works
View as search
Works count:
38
Citation count:
105
H-index:
7
I10-index:
4
Year
Topic
Type